Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Burkitt Lymphoma 14Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Follicular 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma 5Sarcoma, Ewing 3Rhabdomyosarcoma, Embryonal 3Rhabdomyosarcoma 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Down Syndrome 3Rhabdomyosarcoma, Alveolar 2Medulloblastoma 2Lymphoproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Hepatoblastoma 2Wilms Tumor 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma 1Rhabdoid Tumor 1Pleuropulmonary blastoma 1PRETEXT I Hepatoblastoma 1Osteosarcoma 1Neuroblastoma 1

Interventions

temsirolimus 1dehydroftorafur 1Vincristine 1Sirolimus 1Razoxane 1Platinum 1Liver Transplantation 1Irinotecan 1Fluorouracil 1Doxorubicin 1Dexrazoxane 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PRETEXT I Hepatoblastoma × Vincristine × 30 days × Clear all
NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
236 enrolled 18 charts
Gastrointestinal

PRETEXT I Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡